Kingchem (Liaoning) Life Science Co., Ltd. (SHE:301509)
China · Delayed Price · Currency is CNY 38.76
-0.82 (-2.07%)
Feb 11, 2026, 4:00 PM EST
SHE:301509 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 102.75 | 38.61 | 173.57 | 161.45 | 84.55 | 58.94 |
Depreciation & Amortization | 66.89 | 66.89 | 68.1 | 53.94 | 44.54 | 35.59 |
Other Amortization | 0.69 | 0.69 | 0.17 | 0.16 | 0.33 | 0.14 |
Loss (Gain) From Sale of Assets | 0.61 | 0.61 | 0.49 | - | -0.03 | -0.01 |
Asset Writedown & Restructuring Costs | 4.07 | 4.07 | 0.36 | 7.15 | 7.67 | 5.35 |
Loss (Gain) From Sale of Investments | -19.46 | -19.46 | -4.75 | 0.36 | 0.04 | 0.04 |
Stock-Based Compensation | - | - | - | - | 1.86 | - |
Provision & Write-off of Bad Debts | -1.94 | -1.94 | 3.06 | - | 0.86 | 3.32 |
Other Operating Activities | -33.07 | 13.78 | 11.64 | -6.63 | 3.89 | 4.01 |
Change in Accounts Receivable | -42.46 | -42.46 | -97.28 | -60.58 | -35.7 | -25.41 |
Change in Inventory | 9.88 | 9.88 | 5.24 | -61 | -50.65 | -7.2 |
Change in Accounts Payable | 85.48 | 85.48 | -10.37 | 142.4 | 13.24 | 32.5 |
Change in Other Net Operating Assets | 5.86 | 5.86 | 5.37 | 5.58 | - | - |
Operating Cash Flow | 172.19 | 154.9 | 155.16 | 241.55 | 72.27 | 106.06 |
Operating Cash Flow Growth | 26.21% | -0.17% | -35.77% | 234.23% | -31.86% | 49.25% |
Capital Expenditures | -28.56 | -54.1 | -72.9 | -126.69 | -170.66 | -86.93 |
Sale of Property, Plant & Equipment | 0.35 | 0.5 | 0.78 | 0.01 | 0.33 | - |
Investment in Securities | 8,253 | 8,253 | 931.01 | -104.75 | - | - |
Other Investing Activities | -8,577 | -8,576 | -1,797 | - | - | - |
Investing Cash Flow | -351.47 | -375.9 | -937.99 | -231.42 | -170.32 | -86.93 |
Short-Term Debt Issued | - | - | 5 | 32.34 | - | - |
Long-Term Debt Issued | - | - | - | 79.74 | 69.96 | 52.75 |
Total Debt Issued | - | - | 5 | 112.08 | 69.96 | 52.75 |
Short-Term Debt Repaid | - | -5 | -81.93 | - | -32.34 | - |
Long-Term Debt Repaid | - | -1.91 | -2.1 | -72.09 | -75.45 | -58.82 |
Total Debt Repaid | -1.91 | -6.91 | -84.04 | -72.09 | -107.79 | -58.82 |
Net Debt Issued (Repaid) | -1.91 | -6.91 | -79.04 | 39.99 | -37.82 | -6.07 |
Issuance of Common Stock | - | - | 1,130 | - | 105 | 185.5 |
Common Dividends Paid | -47.33 | -69.15 | - | -4.11 | -49.47 | -6.3 |
Other Financing Activities | - | - | -13.45 | -6.18 | -5 | - |
Financing Cash Flow | -49.24 | -76.06 | 1,037 | 29.7 | 12.7 | 173.13 |
Foreign Exchange Rate Adjustments | -1 | 1.34 | 1.25 | 10.13 | -2.31 | -4.28 |
Net Cash Flow | -229.54 | -295.72 | 255.89 | 49.96 | -87.66 | 187.98 |
Free Cash Flow | 143.62 | 100.8 | 82.26 | 114.86 | -98.39 | 19.13 |
Free Cash Flow Growth | 77.92% | 22.54% | -28.39% | - | - | -29.85% |
Free Cash Flow Margin | 24.04% | 20.28% | 10.73% | 16.03% | -17.91% | 4.12% |
Free Cash Flow Per Share | 1.18 | 0.83 | 0.82 | 1.27 | -1.10 | 0.27 |
Cash Interest Paid | - | - | 2.2 | - | - | - |
Cash Income Tax Paid | 18.06 | 13.52 | 8.9 | 5.81 | -3.52 | -8.43 |
Levered Free Cash Flow | 130.56 | 212.07 | -877.86 | 53.95 | -191.05 | 47.76 |
Unlevered Free Cash Flow | 130.72 | 212.27 | -876.48 | 55.64 | -189.5 | 49.78 |
Change in Working Capital | 51.65 | 51.65 | -97.49 | 25.12 | -71.45 | -1.32 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.